Glucagon-like peptide-1 receptor agonists and risk of gastrointestinal cancers: A systematic review and meta-analysis of randomized controlled trials

• Main Authors: Gisella Figlioli (Author), Daniele Piovani (Author), Spyros Peppas (Author), Nicola Pugliese (Author), Cesare Hassan (Author), Alessandro Repici (Author), Ana Lleo (Author), Alessio Aghemo (Author), Stefanos Bonovas (Author)
• Format: Book
• Published: Elsevier, 2024-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are commonly used for glucose lowering and weight-loss. However, their association with gastrointestinal cancer remains uncertain. This meta-analysis assesses the risk of gastrointestinal cancer in patients treated with GLP-1 RAs. Met...